Dora H. Lin

828 total citations
12 papers, 544 citations indexed

About

Dora H. Lin is a scholar working on Pharmacology, Rheumatology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Dora H. Lin has authored 12 papers receiving a total of 544 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Rheumatology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Dora H. Lin's work include Systemic Lupus Erythematosus Research (3 papers), Opioid Use Disorder Treatment (3 papers) and Hormonal and reproductive studies (2 papers). Dora H. Lin is often cited by papers focused on Systemic Lupus Erythematosus Research (3 papers), Opioid Use Disorder Treatment (3 papers) and Hormonal and reproductive studies (2 papers). Dora H. Lin collaborates with scholars based in United States, United Kingdom and Brazil. Dora H. Lin's co-authors include G. Caleb Alexander, Eleanor Lucas, Irene B. Murimi, Geetha Iyer, Sonal Singh, Jonothan C. Tierce, James Heyward, Linda Porter, Christopher M. Jones and Wilson M. Compton and has published in prestigious journals such as The American Journal of Medicine, Addiction and The Lancet Diabetes & Endocrinology.

In The Last Decade

Dora H. Lin

12 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dora H. Lin United States 9 200 141 140 100 73 12 544
Qing‐Bao Tian China 15 122 0.6× 70 0.5× 141 1.0× 22 0.2× 8 0.1× 31 762
Warren Wen United States 14 116 0.6× 21 0.1× 202 1.4× 148 1.5× 194 2.7× 47 737
Michel Mallaret France 11 54 0.3× 40 0.3× 76 0.5× 15 0.1× 18 0.2× 37 549
Ivan Cancarevic United States 14 43 0.2× 84 0.6× 55 0.4× 30 0.3× 5 0.1× 47 524
Antonio Martocchia Italy 13 18 0.1× 73 0.5× 34 0.2× 40 0.4× 17 0.2× 44 480
Julie Watts United States 11 44 0.2× 69 0.5× 118 0.8× 66 0.7× 101 1.4× 11 560
Wen Xu United States 16 68 0.3× 66 0.5× 33 0.2× 161 1.6× 6 0.1× 40 1.1k
Martin Johnson United States 17 177 0.9× 45 0.3× 61 0.4× 24 0.2× 122 1.7× 30 1.3k
G. Veyrac France 11 198 1.0× 7 0.0× 33 0.2× 82 0.8× 6 0.1× 41 531

Countries citing papers authored by Dora H. Lin

Since Specialization
Citations

This map shows the geographic impact of Dora H. Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora H. Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora H. Lin more than expected).

Fields of papers citing papers by Dora H. Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dora H. Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora H. Lin. The network helps show where Dora H. Lin may publish in the future.

Co-authorship network of co-authors of Dora H. Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Dora H. Lin. A scholar is included among the top collaborators of Dora H. Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dora H. Lin. Dora H. Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Lin, Dora H., Irene B. Murimi, Hong Kan, et al.. (2022). Health care utilization and costs of systemic lupus erythematosus in the United States: A systematic review. Lupus. 31(7). 773–807. 6 indexed citations
2.
Lin, Dora H., et al.. (2022). Utilization of submandibular ultrasound in assessing upper airway changes following the administration of propofol. Journal of Anaesthesiology Clinical Pharmacology. 39(4). 583–586. 1 indexed citations
3.
Murimi, Irene B., Dora H. Lin, Henk Nab, et al.. (2020). Association between organ damage and mortality in systemic lupus erythematosus: a systematic review and meta-analysis. BMJ Open. 10(5). e031850–e031850. 63 indexed citations
4.
Murimi, Irene B., Dora H. Lin, Hong Kan, et al.. (2020). Healthcare Utilization and Costs of Systemic Lupus Erythematosus by Disease Severity in the United States. The Journal of Rheumatology. 48(3). 385–393. 38 indexed citations
5.
Alexander, G. Caleb, et al.. (2018). Clinical Development of Biologics Approved by the US Food and Drug Administration, 2003-2016. Therapeutic Innovation & Regulatory Science. 53(6). 752–758. 5 indexed citations
6.
Heyward, James, Christopher M. Jones, Wilson M. Compton, et al.. (2018). Coverage of Nonpharmacologic Treatments for Low Back Pain Among US Public and Private Insurers. JAMA Network Open. 1(6). e183044–e183044. 111 indexed citations
7.
Lin, Dora H., Christopher M. Jones, Wilson M. Compton, et al.. (2018). Prescription Drug Coverage for Treatment of Low Back Pain Among US Medicaid, Medicare Advantage, and Commercial Insurers. JAMA Network Open. 1(2). e180235–e180235. 43 indexed citations
8.
OGASAWARA, K., Christopher D. Breder, Dora H. Lin, & G. Caleb Alexander. (2017). Exposure– and Dose–response Analyses in Dose Selection and Labeling of FDA-approved Biologics. Clinical Therapeutics. 40(1). 95–102.e2. 10 indexed citations
9.
Alexander, G. Caleb, Geetha Iyer, Eleanor Lucas, Dora H. Lin, & Sonal Singh. (2016). Cardiovascular Risks of Exogenous Testosterone Use Among Men: A Systematic Review and Meta-Analysis. The American Journal of Medicine. 130(3). 293–305. 82 indexed citations
10.
Iyer, Geetha, et al.. (2016). Association between exogenous testosterone and cardiovascular events: an overview of systematic reviews. The Lancet Diabetes & Endocrinology. 4(11). 943–956. 77 indexed citations
11.
Lin, Dora H., Eleanor Lucas, Irene B. Murimi, et al.. (2016). Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP). Addiction. 112(2). 311–319. 56 indexed citations
12.
Chiu, Chi‐Tso, Lisa Scheuing, Guangping Liu, et al.. (2015). The Mood Stabilizer Lithium Potentiates the Antidepressant-Like Effects and Ameliorates Oxidative Stress Induced by Acute Ketamine in a Mouse Model of Stress. The International Journal of Neuropsychopharmacology. 18(6). 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026